Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
07/2014
07/31/2014WO2014114742A1 Oxidisable pyridine derivatives, their preparation and use as anti-alzheimer agents
07/31/2014WO2014114706A1 Compositions containing chondroitin sulphate, proteolytic enzymes and sulphydryl compounds for improving the bioavailability of chondroitin sulphate
07/31/2014WO2014114695A1 New pyrimidine derivatives as phosphodiesterase 10 inhibitors (pde-10)
07/31/2014WO2014114694A1 2,3-dihydroimidazol[1,2-c]pyrimidin-5(1h)-one based lipoprotein-associated phospholipase a2 (lp-pla2) inhibitors
07/31/2014WO2014114649A1 Lipase inhibitors
07/31/2014WO2014114627A1 Combinations with 2-aminoethanesulfonic acid
07/31/2014WO2014114578A1 Pyrrolidine derivatives, pharmaceutical compositions and uses thereof
07/31/2014WO2014114575A1 Pharmaceutical composition with improved bioavailability
07/31/2014WO2014114573A1 Antiviral triazole derivatives
07/31/2014WO2014114532A1 Fluoro-[1,3]oxazines as bace1 inhibitors
07/31/2014WO2014114249A1 Bicyclic pyrimidone compounds as inhibitors of lp-pla2
07/31/2014WO2014114248A1 Compounds
07/31/2014WO2014114185A1 Btk inhibitors
07/31/2014WO2014113942A1 Btk inhibitors
07/31/2014WO2014113932A1 Btk inhibitors
07/31/2014WO2014113893A1 Use of galantamine and related compounds for treatment of inflammatory bowel diseases
07/31/2014WO2014113839A1 A method for improving the wellbeing of an animal using a composition including vitamin k
07/31/2014WO2014113836A1 Treatment methods
07/31/2014WO2014089511A3 Administering compositions comprising docosapentaenoic acid
07/31/2014WO2014089121A3 Retrograde delivery of cells and nucleic acids for treatment of cardiovascular diseases
07/31/2014WO2014087367A3 Compositions and methods for the treatment of neurological diseases and its associated complications
07/31/2014WO2014087307A3 Compositions and methods for the treatment of metabolic syndrome and diabetes
07/31/2014WO2014085153A8 6-((s)-1-{1-[5-(2-hydroxy-ethoxy)-pyridin-2-yl]-1h-pyrazol-3-yl}-ethyl)-3h-1,3-benzothiazol-2-one as a tarp-gamma 8 dependent ampa receptor antagonist
07/31/2014WO2014079545A8 Thioether derivatives as protein kinase inhibitors
07/31/2014WO2014078446A3 Skin wound healing and scar reduction with prostaglandin ep4 agonist combinations
07/31/2014WO2014074765A3 Vitamin c, vitamin k, a polyphenol, and combinations thereof for wound healing
07/31/2014WO2014072930A3 Fused pyridine derivatives as antibacterial agents
07/31/2014WO2014072785A3 A process for the preparation of pregabalin
07/31/2014WO2014068463A3 Compositions and methods for the treatment of inflammation and metabolic disorders
07/31/2014WO2014057415A4 Inhibitors of dna gyrase for the treatment of bacterial infections
07/31/2014WO2014052640A8 Novel ampk agonist compositions and methods of use
07/31/2014WO2014043346A3 Anti-pain and anti-nausea and/or vomiting combinatorial compositions
07/31/2014WO2014037903A3 Cosmetic compositions comprising eicosapentaeninic free acid and gamma-linopenic free acid and methods of making and using same
07/31/2014WO2014036502A8 Tetracycline compounds
07/31/2014WO2013117288A8 Tetrahydro-quinazolinone derivatives as tank and parp inhibitors
07/31/2014WO2013082624A3 Materials and methods related to nsaid chemoprevention in colorectal cancer
07/31/2014US20140215644 Soluble protein cd5 or cd6 for the treatment of cancer or tumor or for use as an adjuvant
07/31/2014US20140213990 Compositions and methods for treating surface wounds
07/31/2014US20140213760 Folate Receptor Binding Conjugates of Antifolates
07/31/2014US20140213659 Modified release formulations of memantine oral dosage forms
07/31/2014US20140213657 Lysine specific demethylase-1 inhibitors and their use
07/31/2014US20140213655 Method of treating stroke comprising administering metal chelators to the upper one-third of the nasal cavity
07/31/2014US20140213654 Prostaglandin compositions and methods for the treatment of vasospasm
07/31/2014US20140213653 Directly compressible proprionic acid derivative particles
07/31/2014US20140213651 Novel Use of Adapalene in Treating Cancer
07/31/2014US20140213650 Injectable Nitrogen Mustard Compositions Comprising a Cyclodextrin Derivative and Methods of Making and Using the Same
07/31/2014US20140213649 Stabilized formulation comprising omega-3 fatty acids and use of the fatty acids for skin care and/or wound care
07/31/2014US20140213648 Methods of increasing epa blood levels
07/31/2014US20140213646 Sustained Release Formulations for the Treatment of Intraocular Pressure or Glaucoma
07/31/2014US20140213644 Formulations and Methods for Prevention and Treatment of Oral Allergy Syndrome
07/31/2014US20140213641 Polymeric nanoparticles for drug delivery
07/31/2014US20140213632 HCV Combination Therapy
07/31/2014US20140213631 Methods for modulating kallikrein (klkb1) expression
07/31/2014US20140213630 Methods and pharmaceutical compositions for treating lymphoid malignancy
07/31/2014US20140213629 Molecular targets for healing or treating wounds
07/31/2014US20140213625 Methods and Compositions for Treating Foot or Hand Pain
07/31/2014US20140213624 Method for treating and curing leishmaniosis using fexinidazole
07/31/2014US20140213623 Compounds for treatment of cancer
07/31/2014US20140213622 Pharmaceutical compositions comprising an aromatse inhibitors
07/31/2014US20140213621 Method for treatment of chronic neuropathic pain
07/31/2014US20140213615 Materials and Methods Useful to Induce Vacuolization, Cell Death, or a Combination Thereof
07/31/2014US20140213612 Ppar gamma agonists for treatment of multiple sclerosis
07/31/2014US20140213609 Promoting axon renegeration in the adult cns through control of protein translation
07/31/2014US20140213608 Enhancement of impaired motor and mental functions, using dextromethorphan and oxidase enzyme inhibitor
07/31/2014US20140213607 Enhancement of impaired motor and mental functions, using dextromethorphan and oxidase enzyme inhibitor
07/31/2014US20140213606 Pharmaceutical Formulation Containing Gelling Agent
07/31/2014US20140213605 Methods for treating eye disorders using opioid receptor antagonists
07/31/2014US20140213604 Protein kinase c as a target for the treatment of respiratory syncytial virus
07/31/2014US20140213602 Antitumor agent and therapeutic effect prediction method for patients with kras-mutated colorectal cancer
07/31/2014US20140213600 Medicament for treating peripheral neuropathies
07/31/2014US20140213580 Therapeutically active compositions and their methods of use
07/31/2014US20140213579 Method of weight management
07/31/2014US20140213576 Novel compound useful for the treatment of degenerative and inflammatory diseases
07/31/2014US20140213574 Heteroaryl compounds and uses thereof
07/31/2014US20140213571 Tetracyclic heterocycle compounds and methods of use thereof for the treatment of viral diseases
07/31/2014US20140213570 1,4-disubstituted pyridazine analogs there of and methods for treating smn-deficiency-related conditions
07/31/2014US20140213569 Substituted 6-amino-nicotinamides as KCNQ2/3 modulators
07/31/2014US20140213567 Tazobactam arginine antibiotic compositions
07/31/2014US20140213566 Pharmaceutical Compositions Comprising Beta-Lactam Antibiotic, Sulbactam and Beta-Lactamase Inhibitor
07/31/2014US20140213565 Soluble estradiol capsule for vaginal insertion
07/31/2014US20140213564 Topical compositions and methods for making and using same
07/31/2014US20140213562 Medicinal cosmetic lipoatrophy
07/31/2014US20140213561 Ophthalmic suspension for ocular use
07/31/2014US20140213560 Methods of treating autoimmune, respiratory and inflammatory disorders by inhalation of roflumilast n-oxide
07/31/2014US20140213559 Compositions and treatments for dystrophies
07/31/2014US20140213558 Treatment of inflammatory disease or disorder and compositions therefor
07/31/2014US20140213556 Compositions and methods for combination antiviral therapy
07/31/2014US20140213554 Compounds and methods for kinase modulation, and indications therefor
07/31/2014US20140213553 Carbamoylpyridone derivatives
07/31/2014US20140213552 Cyclohexylamines
07/31/2014US20140213550 Silicate prodrugs and nanoparticles
07/31/2014US20140213545 Compositions and methods of treating viral infections
07/31/2014US20140213542 Composition containing s-adenosyl-l-methionine with excellent storage stability
07/31/2014US20140213537 Resveratrol extraction from gnetum africanum
07/31/2014US20140213536 Marketing n-methylserotonin and related substances for use in treating/ lessening the occurrence of hot flashes related to menopause
07/31/2014US20140213533 Methods to detect, treat and prevent acute cellular rejection in kidney allografts
07/31/2014US20140213532 Compositions and methods for enhancing drug delivery across and into epithelial tissues
07/31/2014US20140213530 Methods for treatment of cancer by targeting sirt5
07/31/2014US20140213524 Composition for regeneration of cartilage
07/31/2014US20140213517 Thermoresponsive, Biodegradable, Elastomeric Material and Uses Therefor